Identification of the optimal therapeutic antibody for fluorescent imaging of cutaneous squamous cell carcinoma

Cancer Biology and Therapy

Volumn 14, Issue 3, 2013, Pages 271-277

  Day, Kristine E ^a   Beck, Lauren N ^a   Heath, C Hope ^a   Huang, Conway C ^b   Zinn, Kurt R ^c   Rosenthal, Eben L ^a  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c University of Alabama   (United States)

Author keywords

Animal model; Antibody; Cancer; Cutaneous squamous cell carcinoma; Fluorescence; Optical imaging; Surgery

Indexed keywords

BEVACIZUMAB; PANITUMUMAB; TOCILIZUMAB;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER SIZE; CONJUGATION; CONTROLLED STUDY; DRUG BINDING; FLUORESCENCE IMAGING; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRAOPERATIVE PERIOD; MOUSE; NONHUMAN; SKIN CARCINOMA;

ANIMAL MODEL; ANTIBODY; CANCER; CUTANEOUS SQUAMOUS CELL CARCINOMA; FLUORESCENCE; OPTICAL IMAGING; SURGERY;

ANIMALS; ANTIBODIES, MONOCLONAL; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; FLUORESCENT DYES; HUMANS; IMMUNOCONJUGATES; INDOLES; MICE; MICROSCOPY, FLUORESCENCE; OPTICAL IMAGING; SKIN NEOPLASMS; TRANSPLANTATION, HETEROLOGOUS;

EID: 84874893293     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.23300     Document Type: Article

References (39)

1. Lomas A, Leonardi-Bee J, Bath-Hextall F. A systematic review of worldwide incidence of nonmelanoma skin cancer. Br J Dermatol 2012; 166:1069-80; PMID:22251204; http://dx.doi.org/10.1111/j.1365-2133.2012.10830.x.
2. Tan PY, Ek E, Su S, Giorlando F, Dieu T. Incomplete excision of squamous cell carcinoma of the skin: a prospective observational study. Plast Reconstr Surg 2007; 120:910-6; PMID:17805118; http://dx.doi. org/10.1097/01.prs. 0000277655.89728.9f. (Pubitemid 47367886)
3. Brougham ND, Dennett ER, Cameron R, Tan ST. The incidence of metastasis from cutaneous squamous cell carcinoma and the impact of its risk factors. J Surg Oncol 2012; 106:811-5; PMID:22592943; http://dx.doi.org/10.1002/jso.23155.
4. Alam M, Ratner D. Cutaneous squamous-cell carcinoma. N Engl J Med 2001; 344:975-83; PMID:11274625; http://dx.doi.org/10.1056/NEJM200103293441306. (Pubitemid 32240317)
5. Talbot S, Hitchcock B. Incomplete primary excision of cutaneous basal and squamous cell carcinomas in the Bay of Plenty. N Z Med J 2004; 117:U848; PMID:15107870.
6. Ang P, Tan AW, Goh CL. Comparison of completely versus incompletely excised cutaneous squamous cell carcinomas. Ann Acad Med Singapore 2004; 33:68-70; PMID:15008566. (Pubitemid 38478113)
7. Bovill ES, Cullen KW, Barrett W, Banwell PE. Clinical and histological findings in re-excision of incompletely excised cutaneous squamous cell carcinoma. J Plast Reconstr Aesthet Surg 2009; 62:457-61; PMID:18218349; http://dx.doi.org/10.1016/j. bjps.2007.11.041.
8. Pugliano-Mauro M, Goldman G. Mohs surgery is effective for high-risk cutaneous squamous cell carcinoma. Dermatol Surg 2010; 36:1544-53; PMID:21053415; http://dx.doi.org/10.1111/j.1524-4725.2010.01576.x.
9. Leibovitch I, Huilgol SC, Selva D, Hill D, Richards S, Paver R. Cutaneous squamous cell carcinoma treated with Mohs micrographic surgery in Australia I. Experience over 10 years. J Am Acad Dermatol 2005; 53:253-60; PMID:16021120; http://dx.doi. org/10.1016/j.jaad.2005.02.059. (Pubitemid 40979582)
10. Keereweer S, Kerrebijn JD, Mol IM, Mieog JS, Van Driel PB, Baatenburg de Jong RJ, et al. Optical imaging of oral squamous cell carcinoma and cervical lymph node metastasis. Head Neck 2012; 34:1002-8; PMID:21987435; http://dx.doi.org/10.1002/hed.21861.
11. Keereweer S, Kerrebijn JD, van Driel PB, Xie B, Kaijzel EL, Snoeks TJ, et al. Optical image-guided surgery-where do we stand? Mol Imaging Biol 2011; 13:199-207; PMID:20617389; http://dx.doi.org/10.1007/s11307-010-0373-2.
12. Scheuer W, van Dam GM, Dobosz M, Schwaiger M, Ntziachristos V. Drug-based optical agents: infiltrating clinics at lower risk. Sci Transl Med 2012; 4:34ps11; PMID:22593172; http://dx.doi.org/10.1126/scitranslmed. 3003572.
13. Bonner JA, De Los Santos J, Waksal HW, Needle MN, Trummel HQ, Raisch KP. Epidermal growth factor receptor as a therapeutic target in head and neck cancer. Semin Radiat Oncol 2002; 12(Suppl 2):11-20; PMID:12174340; http://dx.doi.org/10.1053/srao.2002.34864. (Pubitemid 34920087)
14. Kyzas PA, Stefanou D, Batistatou A, Agnantis NJ. Prognostic significance of VEGF immunohistochemical expression and tumor angiogenesis in head and neck squamous cell carcinoma. J Cancer Res Clin Oncol 2005; 131:624-30; PMID:16044346; http://dx.doi. org/10.1007/s00432-005-0003-6. (Pubitemid 41558557)
15. Thomas GR, Nadiminti H, Regalado J. Molecular predictors of clinical outcome in patients with head and neck squamous cell carcinoma. Int J Exp Pathol 2005; 86:347-63; PMID:16309541; http://dx.doi. org/10.1111/j.0959-9673.2005. 00447.x. (Pubitemid 41746374)
16. Shinriki S, Jono H, Ota K, Ueda M, Kudo M, Ota T, et al. Humanized anti-interleukin-6 receptor antibody suppresses tumor angiogenesis and in vivo growth of human oral squamous cell carcinoma. Clin Cancer Res 2009; 15:5426-34; PMID:19706815; http://dx.doi. org/10.1158/1078-0432.CCR-09-0287.
17. Wang YF, Chang SY, Tai SK, Li WY, Wang LS. Clinical significance of interleukin-6 and interleukin-6 receptor expressions in oral squamous cell carcinoma. Head Neck 2002; 24:850-8; PMID:12211049; http://dx.doi. org/10.1002/hed.10145.
18. Gleysteen JP, Duncan RD, Magnuson JS, Skipper JB, Zinn K, Rosenthal EL. Fluorescently labeled cetuximab to evaluate head and neck cancer response to treatment. Cancer Biol Ther 2007; 6:1181-5; PMID:17637562. (Pubitemid 351590369)
19. Withrow KP, Newman JR, Skipper JB, Gleysteen JP, Magnuson JS, Zinn K, et al. Assessment of bevacizumab conjugated to Cy5.5 for detection of head and neck cancer xenografts. Technol Cancer Res Treat 2008; 7:61-6; PMID:18198926. (Pubitemid 351238697)
20. Terwisscha van Scheltinga AG, van Dam GM, Nagengast WB, Ntziachristos V, Hollema H, Herek JL, et al. Intraoperative near-infrared fluorescence tumor imaging with vascular endothelial growth factor and human epidermal growth factor receptor 2 targeting antibodies. J Nucl Med 2011; 52:1778-85; PMID:21990576; http://dx.doi.org/10.2967/jnumed.111.092833.
21. Heath CH, Deep NL, Sweeny L, Zinn KR, Rosenthal EL. Use of panitumumab-IRDye800 to image microscopic head and neck cancer in an orthotopic surgical model. Ann Surg Oncol 2012; 19:3879-87; PMID:22669455; http://dx.doi.org/10.1245/s10434-012-2435-y.
22. Rosenthal E. ZKR. Optical Imaging of Cancer. New York: Springer, 2009.
23. Mulder WJ, Castermans K, van Beijnum JR, Oude Egbrink MG, Chin PT, Fayad ZA, et al. Molecular imaging of tumor angiogenesis using alphavbeta3-integrin targeted multimodal quantum dots. Angiogenesis 2009; 12:17-24; PMID:19067197; http://dx.doi. org/10.1007/s10456-008-9124-2.
24. Kim JB, Urban K, Cochran E, Lee S, Ang A, Rice B, et al. Non-invasive detection of a small number of bioluminescent cancer cells in vivo. PLoS One 2010; 5:e9364; PMID:20186331; http://dx.doi. org/10.1371/journal.pone.0009364.
25. Wunderbaldinger P, Turetschek K, Bremer C. Nearinfrared fluorescence imaging of lymph nodes using a new enzyme sensing activatable macromolecular optical probe. Eur Radiol 2003; 13:2206-11; PMID:12802615; http://dx.doi.org/10. 1007/s00330-003-1932-6. (Pubitemid 37080758)
26. Mahmood U, Weissleder R. Near-infrared optical imaging of proteases in cancer. Mol Cancer Ther 2003; 2:489-96; PMID:12748311.
27. Wunder A, Straub RH, Gay S, Funk J, Müller-Ladner U. Molecular imaging: novel tools in visualizing rheumatoid arthritis. Rheumatology (Oxford) 2005; 44:1341-9; PMID:15972356; http://dx.doi. org/10.1093/rheumatology/keh709. (Pubitemid 41637634)
28. Kishimoto T. The biology of interleukin-6. Blood 1989; 74:1-10; PMID:2473791. (Pubitemid 19187402)
29. Sweeny L, Dean NR, Magnuson JS, Carroll WR, Helman EE, Hyde SO, et al. EGFR expression in advanced head and neck cutaneous squamous cell carcinoma. Head Neck 2012; 34:681-6; PMID:21739514; http://dx.doi.org/10.1002/hed.21802.
30. Bowden J, Brennan PA, Umar T, Cronin A. Expression of vascular endothelial growth factor in basal cell carcinoma and cutaneous squamous cell carcinoma of the head and neck. J Cutan Pathol 2002; 29:585-9; PMID:12453295; http://dx.doi.org/10.1034/j.1600-0560.2002.291003.x. (Pubitemid 35454442)
31. Adams KE, Ke S, Kwon S, Liang F, Fan Z, Lu Y, et al. Comparison of visible and near-infrared wavelengthexcitable fluorescent dyes for molecular imaging of cancer. J Biomed Opt 2007; 12:024017; PMID:17477732; http://dx.doi.org/10.1117/1.2717137.
32. Dam GMv. VEGF-targeted Fluorescent Tracer Imaging in Breast Cancer. In: ClinicalTrials.gov [Internet]: Bethesda (MD): National Library of Medicine (US). 2000-[cited 2012 Sept 6], 2011.
33. Marshall MV, Draney D, Sevick-Muraca EM, Olive DM. Single-dose intravenous toxicity study of IRDye 800CW in Sprague-Dawley rats. Mol Imaging Biol 2010; 12:583-94; PMID:20376568; http://dx.doi. org/10.1007/s11307-010-0317- x.
34. Keereweer S, Mol IM, Vahrmeijer AL, Van Driel PB, Baatenburg de Jong RJ, Kerrebijn JD, et al. Dual wavelength tumor targeting for detection of hypopharyngeal cancer using near-infrared optical imaging in an animal model. Int J Cancer 2012; 131:1633-40; PMID:22234729; http://dx.doi.org/10.1002/ijc. 27430.
35. Xie BW, Mol IM, Keereweer S, van Beek ER, Que I, Snoeks TJ, et al. Dual-wavelength imaging of tumor progression by activatable and targeting near-infrared fluorescent probes in a bioluminescent breast cancer model. PLoS One 2012; 7:e31875; PMID:22348134; http://dx.doi.org/10.1371/journal.pone. 0031875.
36. Nguyen QT, Olson ES, Aguilera TA, Jiang T, Scadeng M, Ellies LG, et al. Surgery with molecular fluorescence imaging using activatable cell-penetrating peptides decreases residual cancer and improves survival. Proc Natl Acad Sci U S A 2010; 107:4317-22; PMID:20160097; http://dx.doi.org/10.1073/pnas.0910261107.
37. Biosciences L-C. IRDye(R) 800 CW protein labeling kit-high MW. Lincoln, NE. Li-Cor Biosciences 2007; 2007:1-9.
38. Reuthebuch O, Häussler A, Genoni M, Tavakoli R, Odavic D, Kadner A, et al. Novadaq SPY: intraoperative quality assessment in off-pump coronary artery bypass grafting. Chest 2004; 125:418-24; PMID:14769718; http://dx.doi.org/10.1378/chest.125.2.418. (Pubitemid 38223617)
39. Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis. Nat Methods 2012; 9:671-5; PMID:22930834; http://dx.doi. org/10.1038/nmeth.2089.